Immunohistochemical staining of cytokeratin 20 and cytokeratin 7 in colorectal carcinomas: Four different immunostaining profiles
Background/Aim: Aberrant expression of CK20/CK7 is reported in a percentage of colorectal carcinomas (CRC); however, its relation to clinicopathological variables and survival data is still unclear. The objective of this study is to explore patterns of CK20/CK7 immunostaining in CRC and to analyse t...
Main Authors: | Jaudah Al-Maghrabi, Eman Emam, Wafaey Gomaa |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2018-01-01
|
Series: | The Saudi Journal of Gastroenterology |
Subjects: | |
Online Access: | http://www.saudijgastro.com/article.asp?issn=1319-3767;year=2018;volume=24;issue=2;spage=129;epage=134;aulast=Al-Maghrabi |
Similar Items
-
Cytokeratin 7 and cytokeratin 20 expression in cancer: A tissue microarray study on 15,424 cancers
by: Bernreuther, C., et al.
Published: (2022) -
The value of CDX2 and cytokeratins 7 and 20 expression in differentiating colorectal adenocarcinomas from extraintestinal gastrointestinal adenocarcinomas: cytokeratin 7-/20+ phenotype is more specific than CDX2 antibody
by: Bayrak Reyhan, et al.
Published: (2012-01-01) -
Cytokeratin 20-positive hepatocellular carcinoma
by: G. Faa, et al.
Published: (2009-12-01) -
Cytokeratin 20-positive hepatocellular carcinoma
by: D. Fanni, et al.
Published: (2009-12-01) -
Cytokeratin 5/6 and cytokeratin 8/18 expression in triple negative breast cancers: clinicopathologic significance in South-Asian population
by: Atif Ali Hashmi, et al.
Published: (2018-06-01)